CymitQuimica logo

CAS 11006-66-9

:

(4E,6R,7E,9E,11E,14S,15E,17E,19E,22S)-22-[(1S,2S,3S,5E,7E,9E,11S,12S)-12-[(6-Deoxy-2,4-di-O-methyl-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrien-1-yl]-6,14-dihydroxy-5,8,12-trimethyloxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione

Description:
The chemical substance with the name "(4E,6R,7E,9E,11E,14S,15E,17E,19E,22S)-22-[(1S,2S,3S,5E,7E,9E,11S,12S)-12-[(6-Deoxy-2,4-di-O-methyl-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrien-1-yl]-6,14-dihydroxy-5,8,12-trimethyloxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione" and CAS number "11006-66-9" is a complex organic molecule characterized by its intricate stereochemistry and multiple functional groups. It features a series of double bonds and hydroxyl groups, indicating potential reactivity and biological activity. The presence of a sugar moiety suggests it may have glycosidic properties, which could influence its solubility and interaction with biological systems. This compound is likely to exhibit significant structural diversity due to its multiple stereocenters, which can affect its pharmacological properties. Such molecules are often studied for their potential applications in pharmaceuticals, particularly in the context of natural products or bioactive compounds. The detailed structure implies a potential role in biochemical pathways, possibly as a signaling molecule or in metabolic processes.
Formula:C47H66O13
InChI:InChI=1/C47H66O13/c1-29-20-19-21-31(3)42(53)38(50)24-17-11-10-12-18-25-40(60-41(52)27-26-30(2)39(51)28-29)33(5)43(54)32(4)36(48)22-15-13-14-16-23-37(49)34(6)58-47-46(57-9)44(55)45(56-8)35(7)59-47/h10-24,26,28,32-35,37-40,43-47,49-51,54-55H,25,27H2,1-9H3/b11-10+,14-13+,18-12+,20-19+,22-15+,23-16+,24-17+,29-28+,30-26-,31-21+/t32?,33?,34?,35-,37?,38?,39?,40?,43?,44+,45+,46-,47-/m1/s1
Synonyms:
  • (4E,6R,7E,9E,11E,14S,15E,17E,19E,22S)-22-[(1S,2S,3S,5E,7E,9E,11S,12S)-12-[(6-Deoxy-2,4-di-O-methyl-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrien-1-yl]-6,14-dihydroxy-5,8,12-trimethyloxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione
  • Pulvomycin
  • Antibiotic 1063Z
  • Labilomycin
  • Oxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione, 22-(12-((6-deoxy-2,4-di-O-methyl-beta-D-galactopyranosyl)oxy)-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrienyl)-6,14-dihydroxy-5,8,12-trimethyl-
  • Labilomycin (8CI)
  • Oxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione, 22-[(1S,2S,3S,5E,7E,9E,11S,12S)-12-[(6-deoxy-2,4-di-O-methyl-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrien-1-yl]-6,14-dihydroxy-5,8,12-trimethyl-, (4E,6R,7E,9E,11E,14S,15E,17E,19E,22S)-
  • (3E,5E,7E)-12-[(4E,6E,8E,12E,14E,16E,19Z)-10,18-dihydroxy-12,16,19-trimethyl-11,22-dioxooxacyclodocosa-4,6,8,12,14,16,19-heptaen-2-yl]-2,11-dihydroxy-1,10-dimethyl-9-oxotrideca-3,5,7-trien-1-yl 6-deoxy-2,4-di-O-methyl-beta-D-galactopyranoside
  • Oxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione, 22-[(1S,2S,3S,5E,7E,9E,11S,12S)-12-[(6-deoxy-2,4-di-O-methyl-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrienyl]-6,14-dihydroxy-5,8,12-trimethyl-, (4E,6R,7E,9E,11E,14S,15E,17E,19E,22S)-
  • pulmycin
  • 22-[12-[(2-O,4-O-Dimethyl-6-deoxy-β-D-galactopyranosyl)oxy]-2,11-dihydroxy-1,3-dimethyl-4-oxo-5,7,9-tridecatrienyl]-6,14-dihydroxy-5,8,12-trimethyloxacyclodocosa-4,7,9,11,15,17,19-heptene-2,13-dione
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • Pulvomycin
    Targetmol
    + Info

    Pulvomycin

    CAS:
    <p>Pulvomycin is a protein biosynthesis inhibitor preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA.</p>
    Formula:C47H66O13
    Purity:98%
    Color and Shape:Solid
    Molecular weight:839.032

    Ref: TM-T26001